Processing 00000000.tx.1: Analysis of the Type 2 Diabetes-Associated Single Nucleotide Polymorphisms in the Genes IRS1, KCNJ11, and PPARG2 in Type 1 Diabetes Christina Eftychi1, Joanna M.M. 

Phrase: "Analysis of the Type 2 Diabetes-Associated Single Nucleotide Polymorphisms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C3536614:Single nucleotide polymorphism analysis [Laboratory Procedure]
   741   C0796451:polymorphism analysis [Diagnostic Procedure]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "in the Genes IRS1,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   937   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   840   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C1334133:INSULIN RECEPTOR [Gene or Genome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1710236:Substrate [Manufactured Object]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "KCNJ11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:KCNJ11 [Gene or Genome]

Phrase: "and"

Phrase: "PPARG2 in Type 1 Diabetes Christina Eftychi1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   751   C0314611:Gene type [Genetic Function]
   751   C1335671:Receptor Gene [Gene or Genome]
   736   C0017337:Gene [Gene or Genome]

Phrase: "Joanna"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1653801:Joanna [Eukaryote]

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Howson1, Bryan J. 

Phrase: "Howson1,"

Phrase: "Bryan J."
Processing 00000000.tx.3: Barratt1, Adrian Vella1, Felicity Payne1, Deborah J. 

Phrase: "Barratt1,"

Phrase: "Adrian Vella1,"

Phrase: "Felicity Payne1,"

Phrase: "Deborah J."
Processing 00000000.tx.4: Smyth1, Rebecca C.J. 

Phrase: "Smyth1,"

Phrase: "Rebecca C.J."
Processing 00000000.tx.5: Twells1, Neil M. 

Phrase: "Twells1,"

Phrase: "Neil M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.6: Walker1, Helen E. 

Phrase: "Walker1,"

Phrase: "Helen E."
Processing 00000000.tx.7: Rance1, Eva Tuomilehto-Wolf2, Jaakko Tuomilehto2,3, Dag E. 

Phrase: "Rance1,"

Phrase: "Eva Tuomilehto-Wolf2,"

Phrase: "Jaakko Tuomilehto2,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Dag E."
Processing 00000000.tx.8: Undlien4, Kjersti S. 

Phrase: "Undlien4,"

Phrase: "Kjersti S."
Processing 00000000.tx.9: Rnningen5, Cristian Guja6, Constantin Ionescu-Tirgovite6, David A. 

Phrase: "Rnningen5,"

Phrase: "Cristian Guja6,"

Phrase: "Constantin Ionescu-Tirgovite6,"

Phrase: "David A."
Processing 00000000.tx.10: Savage7, and John A. 

Phrase: "Savage7,"

Phrase: "and"

Phrase: "John A."
Processing 00000000.tx.11: Todd1 1 Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, U.K 2 Diabetes and Genetic Epidemiology Unit, National Public Health Institute, University of Helsinki, Helsinki, Finland 3 Department of Public Health, University of Helsinki, Helsinki, Finland 4 Institute of Medical Genetics, Ulleval University Hospital, University of Oslo, Oslo, Norway 5 Laboratory of Molecular Epidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway 6 Clinic of Diabetes, Institute of Diabetes, Nutrition and Metabolic Diseases, Bucharest, Romania 7 Department of Medical Genetics, Queens University Belfast, Belfast City Hospital, Belfast, Northern Ireland  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS REFERENCES  It has been proposed that type 1 and 2 diabetes might share common pathophysiological pathways and, to some extent, genetic background. 

Phrase: "Todd1 1 Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes"

Phrase: "and"

Phrase: "Inflammation Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Cambridge Institute for Medical Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0035172:Research Institute [Organization]
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "University of Cambridge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Cambridge,"

Phrase: "U.K 2 Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Genetic Epidemiology Unit,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C2826314:Original Unit [Quantitative Concept]
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]
   734   C0872180:Genetic Epidemiology [Occupation or Discipline]

Phrase: "National Public Health Institute,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0027468:national health institute [Health Care Related Organization]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "University of Helsinki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Helsinki,"

Phrase: "Finland 3 Department of Public Health,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0034019:Public Health [Biomedical Occupation or Discipline]
   827   C0699943:public health [Health Care Activity]
   827   C3244304:public health [Intellectual Product]
   799   C0018684:Health [Idea or Concept]
   799   C1704729:Department [Organization]

Phrase: "University of Helsinki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Helsinki,"

Phrase: "Finland 4 Institute of Medical Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]

Phrase: "Ulleval University Hospital,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "University of Oslo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Oslo,"

Phrase: "Norway 5 Laboratory of Molecular Epidemiology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0022877:Laboratory [Manufactured Object,Organization]
   753   C3244292:laboratory [Functional Concept]

Phrase: "Division of Epidemiology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "Norwegian Institute of Public Health,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   840   C0034019:Public Health [Biomedical Occupation or Discipline]
   840   C0699943:public health [Health Care Activity]
   840   C3244304:public health [Intellectual Product]
   804   C0018684:Health [Idea or Concept]
   804   C0021622:institute [Organization]
   804   C0337812:Norwegian [Population Group]
   804   C1272753:Institute [Idea or Concept]
   704 E C0031206:healthiness [Finding]

Phrase: "Oslo,"

Phrase: "Norway 6 Clinic of Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0442592:Clinic [Health Care Related Organization,Manufactured Object]

Phrase: "Institute of Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "Nutrition"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0028707:Nutrition [Biomedical Occupation or Discipline]
  1000   C0392209:nutrition [Organism Attribute]
  1000   C1442959:Nutrition [Organism Function]
   928 E C1521739:Nutritional [Qualitative Concept]
   928 E C2707262:Nutritional [Clinical Attribute]

Phrase: "and"

Phrase: "Metabolic Diseases,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0025517:Metabolic Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "Bucharest,"

Phrase: "Romania 7 Department of Medical Genetics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0587450:Medical department [Health Care Related Organization]
   783   C0587466:Genetics department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "Queens University Belfast,"

Phrase: "Belfast City Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0020029:Hospital, City [Health Care Related Organization]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Belfast,"

Phrase: "Northern Ireland  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that type 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441729:Type 1 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "might"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "common pathophysiological pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: ","

Phrase: "to some extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "genetic background."
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]
Processing 00000000.tx.12: However, to date there has been no convincing data to establish a molecular genetic link between them. 

Phrase: "However,"

Phrase: "to date there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011008:Date [Temporal Concept]
   861   C2348077:Date [Food]

Phrase: "has"

Phrase: "been"

Phrase: "no convincing data to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "a molecular genetic link between them."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]
Processing 00000000.tx.13: We have genotyped three single nucleotide polymorphisms associated with type 2 diabetes in a large type 1 diabetic family collection of European descent: Gly972Arg in the insulin receptor substrate 1 (IRS1) gene, Glu23Lys in the potassium inwardly-rectifying channel gene (KCNJ11), and Pro12Ala in the peroxisome proliferative-activated receptor 2 gene (PPARG2). 

Phrase: "We"

Phrase: "have"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "three single nucleotide polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in a large type 1 diabetic family collection"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C2700055:Family Collection [Classification]
   799   C1516698:Collection [Functional Concept]
   799   C1704814:Collection [Idea or Concept]
   727 E C1516695:Collected [Idea or Concept]
   709   C0424972:Large family [Family Group]

Phrase: "of European descent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680043:descent [Family Group]

Phrase: ":"

Phrase: "Gly972Arg in the insulin receptor substrate 1 (IRS1) gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   703   C1334140:Insulin Receptor Substrate 1 Gene [Gene or Genome]

Phrase: "Glu23Lys in the potassium inwardly-rectifying channel gene"

Phrase: "(KCNJ11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:KCNJ11 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Pro12Ala in the peroxisome proliferative-activated receptor 2 gene (PPARG2)."
Processing 00000000.tx.14: We were unable to confirm a recently published association of the IRS1 Gly972Arg variant with type 1 diabetes. 

Phrase: "We"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "a recently published association of the IRS1 Gly972Arg variant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0004083:Association [Mental Process]
   736   C0439849:Association [Qualitative Concept]
   736   C0596306:Association [Phenomenon or Process]
   736   C0699792:association [Social Behavior]

Phrase: "with type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.15: Moreover, KCNJ11 Glu23Lys showed no association with type 1 diabetes (P > 0.05). 

Phrase: "Moreover,"

Phrase: "KCNJ11 Glu23Lys"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no association with type 1 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C3645563:Association type [Intellectual Product]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "(P > 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.16: However, the PPARG2 Pro12Ala variant showed evidence of association (RR 1.15, 95% CI 1.041.28, P = 0.008). 

Phrase: "However,"

Phrase: "the PPARG2 Pro12Ala variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205419:Variant [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "(RR 1.15,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0242492:Relative Risk [Quantitative Concept]
   861   C0966318:RISK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0035647:Risk [Qualitative Concept]
   812   C0080103:Relative [Family Group]
   812   C0205345:Relative [Qualitative Concept]
   812   C1547039:*Relative [Quantitative Concept]

Phrase: "95% CI 1.041.28,"

Phrase: "P = 0.008"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.17: Additional studies need to be conducted to confirm this result. 

Phrase: "Additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this result."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]
Processing 00000000.tx.18: Type 1 and 2 diabetes have been considered genetically and pathophysiologically distinct diseases, although clinically, it can sometimes be difficult to distinguish between them in individuals with deficient or absent endogenous insulin secretion, a feature common to both categories. 

Phrase: "Type 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441729:Type 1 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "have"

Phrase: "been"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "genetically"

Phrase: "and"

Phrase: "pathophysiologically distinct diseases,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]

Phrase: "although"

Phrase: "clinically,"

Phrase: "it"

Phrase: "can"

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "be"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "distinguish between them"

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with deficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011155:Deficient [Functional Concept]
  1000   C1636779:% deficient [Quantitative Concept]

Phrase: "or"

Phrase: "absent endogenous insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "common to both categories."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]
Processing 00000000.tx.19: Evidence does exist suggesting that there may be shared etiological features (13). 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "does"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "may"

Phrase: "be"

Phrase: "shared"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237876:shared [Social Behavior]
  1000   C1522138:Shared [Functional Concept]

Phrase: "etiological features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.20: Occasionally, individuals who develop diabetes late in life initially present in a similar manner to type 2 diabetes, but develop progressive -cell failure together with evidence of autoimmunity to islet cells, which is characteristic of type 1 diabetes. 

Phrase: "Occasionally,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Occasionally [Temporal Concept]

Phrase: "individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "who"

Phrase: "develop"

Phrase: "diabetes late in life initially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]

Phrase: "present in a similar manner"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "to type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "but"

Phrase: "develop"

Phrase: "progressive -cell failure together with evidence of autoimmunity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0231174:Failure [Functional Concept]
   744   C0680095:failure [Individual Behavior]

Phrase: "to islet cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "is"

Phrase: "characteristic of type 1 diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C3645613:Characteristic type [Intellectual Product]
   760   C1521970:Characteristic [Qualitative Concept]
Processing 00000000.tx.21: This so-called latent autoimmune diabetes in adults could suggest an overlap in the pathogenesis of type 1 and 2 diabetes in some cases. 

Phrase: "This so-called latent autoimmune diabetes in adults"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   767   C0271650:Latent diabetes [Disease or Syndrome]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0205275:Latent [Qualitative Concept]
   744   C0443146:Autoimmune [Pathologic Function]

Phrase: "could"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an overlap in the pathogenesis of type 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0185027:overlap [Therapeutic or Preventive Procedure]
   744   C1948020:Overlap [Conceptual Entity]

Phrase: "and"

Phrase: "2 diabetes in some cases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.22: Furthermore, a recent study (4) has reported that early in the course of type 1 diabetes, individuals with evidence of islet autoimmunity may have normal fasting glucose but abnormal postprandial glucose tolerance. 

Phrase: "Furthermore,"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(4"

Phrase: ")"

Phrase: "has"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that early in the course of type 1 diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1279919:Early [Temporal Concept]

Phrase: "individuals with evidence of islet autoimmunity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "may"

Phrase: "have"

Phrase: "normal fasting glucose"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0860800:normal glucose [Finding]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: "but"

Phrase: "abnormal postprandial glucose tolerance."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0235401:Abnormal glucose tolerance [Finding]
   861   C0178665:Glucose tolerance [Physiologic Function]
   812   C0013220:Tolerance [Finding]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C1704410:Tolerance [Qualitative Concept]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]
   708   C0580546:Abnormal glucose [Finding]
Processing 00000000.tx.23: This pattern of defective postprandial secretion of insulin in response to nutrient intake is often observed in type 2 diabetes as well (4). 

Phrase: "This pattern of defective postprandial secretion of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Pattern [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to nutrient intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006777:Nutrient intake [Quantitative Concept]
   861   C1512806:Intake [Functional Concept]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "observed in type 2 diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "as well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.24: There has been some evidence of familial clustering of type 1 and 2 diabetes (5,6). 

Phrase: "There"

Phrase: "has"

Phrase: "been"

Phrase: "some evidence of familial clustering of type 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.25: However, the HLA region, the major locus in type 1 diabetes, has only infrequently been associated with type 2 diabetes (7). 

Phrase: "However,"

Phrase: "the HLA region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "the major locus in type 1 diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1708726:Locus [Gene or Genome]

Phrase: "has"

Phrase: "only infrequently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0521114:Infrequently [Temporal Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "been"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.26: Moreover, both diseases have been associated with variation in the insulin gene but with predisposition determined by opposite alleles of the 5' variable number tandem repeat locus (8). 

Phrase: "Moreover,"

Phrase: "both diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "associated with variation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0205419:Variation [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "but with predisposition"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0012655:Predisposition [Clinical Attribute]
   790   C0220898:Predisposition [Organism Attribute]
   790   C0233535:but [Mental or Behavioral Dysfunction]
   718 E C0231203:Predisposed [Functional Concept]

Phrase: "determined by opposite alleles of the 5' variable number tandem repeat locus"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0242827:Variable Number Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1710347:Variable Number Tandem Repeat [Cell or Molecular Dysfunction]
   767   C3179163:Variable Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0039290:Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0002085:Alleles [Gene or Genome]
   736   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   736   C0205341:Repeat [Functional Concept]
   736   C0237753:*Number [Quantitative Concept]
   736   C0439828:Variable [Qualitative Concept]
   736   C0449788:Number [Quantitative Concept]
   736   C1521805:Opposite [Spatial Concept]
   736   C1547730:Repeat [Temporal Concept]
   736   C1705914:Repeat [Conceptual Entity]
   736   C1708726:Locus [Gene or Genome]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.27: Recently, genetic studies in type 2 diabetes have begun to reveal disease-associated polymorphisms that have established some level of general acceptance because they have been replicated by independent studies. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "genetic studies in type 2 diabetes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   773   C2827447:Genetic Study [Research Activity]
   767   C0035171:Study Type [Research Activity]
   767   C2985227:Study Type [Research Activity]
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "begun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "disease-associated polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "that"

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "some level of general acceptance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "because"

Phrase: "they"

Phrase: "have"

Phrase: "been"

Phrase: "replicated by independent studies."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   816   C0681367:independent study [Educational Activity]
   770   C0085862:Independent [Idea or Concept]
   770   C0205173:replicated [Functional Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1299583:Independent [Finding]
   737 E C0205341:Replicate [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1883725:Replicate [Qualitative Concept]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.28: Two polymorphisms that are well established as associated with type 2 diabetes are the single nucleotide polymorphisms (SNPs) Pro12Ala in the peroxisome proliferator-activated receptor gene isoform 2 (PPARG2), resulting from a C>G transversion, and Glu23Lys in the potassium inwardly rectifying channel gene (KCNJ11), resulting from an A>G transition (9). 

Phrase: "Two polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "well established"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C0443211:Established [Qualitative Concept]
   861   C1272684:Established [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "as"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "are"

Phrase: "the single nucleotide polymorphisms (SNPs) Pro12Ala"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]

Phrase: "in the peroxisome proliferator-activated receptor gene isoform 2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   877   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   877   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   818   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   818   C1335671:Receptor Gene [Gene or Genome]
   795   C0017337:Gene [Gene or Genome]
   795   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0752063:Peroxysome [Cell Component]
   795   C1879547:Activated [Activity]
   795   C2984308:Peroxisome [Functional Concept]
   762 E C1515877:Activate [Functional Concept]
   724 E C3546463:peroxisomal [Cell Component]

Phrase: "(PPARG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C1335671:Receptor Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "resulting from a C>G transversion,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0439267:g% [Quantitative Concept]
   753   C0599157:Transversion [Cell or Molecular Dysfunction]
   753   C0678226:resulting [Functional Concept]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "Glu23Lys in the potassium inwardly"

Phrase: "rectifying"

Phrase: "channel gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "(KCNJ11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:KCNJ11 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "resulting from an A>G transition"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0439267:g% [Quantitative Concept]
   753   C0599156:Transition [Cell or Molecular Dysfunction]
   753   C0678226:resulting [Functional Concept]
   753   C2700061:Transition [Activity]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.29: The reported effect sizes are modest (odds ratio [OR] 1.21.3) in meta-analyses (9,10). 

Phrase: "The reported effect sizes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0814843:effect sizes [Quantitative Concept]
   827   C0456389:SIZES [Spatial Concept]

Phrase: "are"

Phrase: "modest"

Phrase: "(odds ratio [OR] 1.21.3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0028873:Odds Ratio [Quantitative Concept]
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: ")"

Phrase: "in meta-analyses"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0920317:meta-analyses [Research Activity]
   966 E C0282458:Meta-Analysis [Intellectual Product]
   861   C1042496:Meta [Eukaryote]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.30: A large collaborative collection of type 1 diabetic families is now available for genetic analysis (11) with sufficient power to detect effects in the OR range of 1.21.3. 

Phrase: "A large collaborative collection of type 1 diabetic families"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0445613:Type of collection [Intellectual Product]
   762   C2700055:Family Collection [Classification]
   742   C1516698:Collection [Functional Concept]
   742   C1704814:Collection [Idea or Concept]

Phrase: "is"

Phrase: "now available for genetic analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470187:Available [Functional Concept]

Phrase: "(11"

Phrase: ")"

Phrase: "with sufficient power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "effects in the OR range of 1.21.3."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.31: Hence, in the present report we investigated the possibility that the two type 2 diabetes-associated SNPs were also associated with type 1 diabetes in an effort to begin to establish if overlaps exist in the two disease pathways. 

Phrase: "Hence,"

Phrase: "in the present report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the two type 2 diabetes-associated SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   835   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   793   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0032529:polymorphisms [Genetic Function]
   793   C0037179:Single [Population Group]
   793   C0087136:single [Finding]
   793   C0205171:Single [Quantitative Concept]
   760 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "associated with type 1 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in an effort to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015264:Effort [Organism Function]

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "if"

Phrase: "overlaps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0185027:overlap [Therapeutic or Preventive Procedure]
   966   C1948020:Overlap [Conceptual Entity]

Phrase: "exist in the two disease pathways."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   773   C1511986:Disease Pathway [Conceptual Entity]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205448:Two [Quantitative Concept]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
   753   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.32: We have also tested the insulin receptor substrate 1 (IRS1) Gly972Arg polymorphism because it has been reported to be associated with type 1 diabetes (12), although it is not as well established in type 2 diabetes as the PPARG2 and KCNJ11 SNPs. 

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the insulin receptor substrate 1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IRS1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "Gly972Arg polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "because"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with type 1 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "it"

Phrase: "is"

Phrase: "not as well established"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205170:Well [Qualitative Concept]
   770   C0443211:Established [Qualitative Concept]
   770   C1272684:Established [Qualitative Concept]
   770   C1518422:Not [Functional Concept]
   770   C3146287:Well [Manufactured Object]

Phrase: "in type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "as the PPARG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C1335671:Receptor Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "KCNJ11 SNPs."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.33: The PPARG gene encodes peroxisome proliferator-activated receptor (PPAR), a member of the nuclear receptor superfamily that has regulatory functions in adipocyte differentiation and glucose homeostasis (13). 

Phrase: "The PPARG gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335238:PPARG gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "peroxisome proliferator-activated receptor (PPAR),"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "a member of the nuclear receptor superfamily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: "that"

Phrase: "has"

Phrase: "regulatory functions in adipocyte differentiation"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0542341:Functions [Functional Concept]
   756   C2752631:functional differentiation [Cell Function]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "glucose homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1326961:glucose homeostasis [Physiologic Function]
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.34: PPAR is a target for a large family of antidiabetic drugs, the thiazolidinediones, that act as PPAR agonists and increase hepatic and peripheral insulin action in type 2 diabetes (14). 

Phrase: "PPAR"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "is"

Phrase: "a target for a large family of antidiabetic drugs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0085104:drugs target [Medical Device]
   742   C1521840:Target [Functional Concept]
   742   C2986546:TARGET [Diagnostic Procedure]

Phrase: "the thiazolidinediones,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "that"

Phrase: "act as PPAR agonists"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   853   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   853   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   778   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C0243192:agonists [Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0752063:Peroxysome [Cell Component]
   748   C1879547:Activated [Activity]
   748   C2984308:Peroxisome [Functional Concept]
   748   C2987634:agonists [Pharmacologic Substance]
   714 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "hepatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "peripheral insulin action in type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205100:Peripheral [Spatial Concept]
   748   C0441472:Action [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C3266814:Action [Activity]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.35: In a meta-analysis of published studies through February 2003 (9), an OR of 1.27 was estimated for the Pro allele of isoform 2 (P value <2 x 10-8) in type 2 diabetes. 

Phrase: "In a meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "of published studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "through February 2003"

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "an OR of 1.27"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "estimated for the Pro allele of isoform 2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0002085:Allele [Gene or Genome]
   744   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   744   C0750572:Estimated [Quantitative Concept]
   744   C2987124:PRO [Intellectual Product]

Phrase: "(P value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709380:P-Value [Quantitative Concept]
   861   C1522609:Value [Quantitative Concept]

Phrase: "<2 x 10-8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "in type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.36: This association is supported by functional data, as in vitro studies have shown that the Ala allele decreases the DNA-binding affinity of the PPAR2, thus reducing its transcriptional activity (15). 

Phrase: "This association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "is"

Phrase: "supported by functional data,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0205245:Functional [Functional Concept]
   770   C0542341:Functional [Functional Concept]
   770   C1511726:Data [Idea or Concept]
   770   C1521721:Supported [Conceptual Entity]
   770   C2700217:Functional [Conceptual Entity]
   770   C3245479:data [Medical Device]
   737 E C0183683:Support [Medical Device]

Phrase: "as"

Phrase: "in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the Ala allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the DNA-binding affinity of the PPAR2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "thus"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "its transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.37: The KCNJ11 Glu23Lys variant has also been consistently reported (10,16,17) to be associated with type 2 diabetes. 

Phrase: "The KCNJ11 Glu23Lys variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "consistently"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(10,"

Phrase: "16,"

Phrase: "17"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with type 2 diabetes."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.38: KCNJ11 encodes for KIR6.2, which comprises one of the two subunits of the -cell ATP-sensitive potassium channel that regulates insulin secretion. 

Phrase: "KCNJ11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:KCNJ11 [Gene or Genome]

Phrase: "encodes for KIR6.2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1416578:Kir6.2 [Gene or Genome]
   770   C2700640:Encode [Activity]

Phrase: "which"

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "one of the two subunits of the -cell ATP-sensitive potassium channel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "regulates"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.39: A meta-analysis combining published case-control studies up to September 2002 (10) gave an OR of 1.23 (95% CI 1.121.36, P = 1.5 x 10-5) for the Lys allele, suggesting that this allele is associated with type 2 diabetes. 

Phrase: "A meta-analysis combining published case-control studies up to September 2002"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   770   C0007328:Case-Control Studies [Research Activity]
   753   C0872128:case control [Health Care Activity]
   751   C0085973:Case Studies [Intellectual Product]
   736   C0243148:control [Qualitative Concept]
   736   C0868928:Case [Functional Concept]
   736   C0947630:studies [Laboratory Procedure]
   736   C1550141:Control [Substance]
   736   C1706255:CASE [Medical Device]
   736   C1706256:Case [Conceptual Entity]
   736   C1882979:Control [Conceptual Entity]
   736   C2587213:Control [Functional Concept]
   736   C3274648:Control [Qualitative Concept]
   703 E C0557651:Study [Manufactured Object]
   703 E C2603343:Study [Research Activity]

Phrase: "(10"

Phrase: ")"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "an OR of 1.23"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "(95% CI 1.121.36,"

Phrase: "P = 1.5 x 10-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "for the Lys allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "associated with type 2 diabetes."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.40: In addition, functional data shows that the Lys variant may alter type 2 diabetes susceptibility by increasing the threshold ATP concentration necessary for insulin release, thus inducing spontaneous overactivity of pancreatic -cells (18). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "functional data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the Lys variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "may"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "type 2 diabetes susceptibility by increasing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "the threshold ATP concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "necessary for insulin release,"

Phrase: "thus"

Phrase: "inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "spontaneous overactivity of pancreatic -cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0474395:overactivity [Finding]
   760   C1536696:Overactivity [Finding]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.41: Increasing the metabolic activity of -cells might confer susceptibility to type 1 diabetes as well (19). 

Phrase: "Increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the metabolic activity of -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "might"

Phrase: "confer"

Phrase: "susceptibility to type 1 diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "as well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.42: The insulin receptor substrate proteins (IRS1 and IRS2) are expressed in a variety of insulin responsive cells and tissues, mediating metabolic and growth-promoting actions of insulin and IGF-1. 

Phrase: "The insulin receptor substrate proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2350409:Insulin Receptor Substrate Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0597357:receptor proteins [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(IRS1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IRS2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334141:IRS2 [Gene or Genome]
  1000   C1334191:IRS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "are"

Phrase: "expressed in a variety of insulin responsive cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   750   C0030281:Insulin Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0205342:Responsive [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1883525:Variety [Conceptual Entity]
   744   C2346866:Variety [Conceptual Entity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311400:Metabolic [Functional Concept]
  1000   C1524026:Metabolic [Cell Function]
  1000   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "growth-promoting actions of insulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C2911660:Growth action [Activity]
   760   C0441472:actions [Functional Concept]
   726 E C3266814:Action [Activity]

Phrase: "and"

Phrase: "IGF-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.43: Observations from knockout mice suggest a role for these proteins in regulation of -cell function (20), and the human IRS1 Gly972Arg variant has been reported to be associated with type 2 diabetes (9). 

Phrase: "Observations from knockout mice"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0302523:observations [Research Activity]
   770   C0700325:observations [Health Care Activity]
   770   C3244290:observations [Functional Concept]
   737 E C1964257:Observation [Diagnostic Procedure]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role for these proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in regulation of -cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0007613:Cell Function [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1705273:Function [Intellectual Product]
   812   C1948049:Cell [Spatial Concept]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the human IRS1 Gly972Arg variant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0205419:Variant [Qualitative Concept]
   710   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.44: Meta-analysis, based on 3,408 case subjects and 5,419 control subjects from studies before January 2002 (21), resulted in an OR of 1.25 (95% CI 1.051.48). 

Phrase: "Meta-analysis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "based on 3,408 case subjects"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   753   C0868928:Case [Functional Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719 E C1880279:Base [Biomedical or Dental Material]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "5,419 control subjects from studies"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   750   C0681850:Study Subject [Group]
           Subject
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "before January 2002"

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "resulted in an OR of 1.25"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0028873:Odds Ratio [Quantitative Concept]
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "(95% CI 1.051.48"

Phrase: ")."
Processing 00000000.tx.45: Of direct relevance to our study is a recent study (12) reporting an association of this variant with type 1 diabetes, with an OR of 2.5 (P = 0.0008) in a case-control study and a transmission/disequilibrium test (TDT) in simplex families giving a P value <0.02. 

Phrase: "Of direct relevance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevance [Qualitative Concept]

Phrase: "to our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(12"

Phrase: ")"

Phrase: "reporting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0700287:Reporting [Health Care Activity]
   966 E C0684224:Report [Intellectual Product]
   966 E C3273238:Report [Intellectual Product]

Phrase: "an association of this variant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with type 1 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "with an OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "of 2.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(P = 0.0008"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in a case-control study"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0007328:Case-Control Study [Research Activity]
   913   C0085973:Case Study [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0868928:Case [Functional Concept]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2603343:Study [Research Activity]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "a transmission/disequilibrium test"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0040722:transmission [Idea or Concept]
   827   C0242781:Transmission [Pathologic Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0392366:test [Intellectual Product]
   827   C0394006:Disequilibrium [Disease or Syndrome]
   827   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "(TDT) in simplex families"

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a P value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709380:P-Value [Quantitative Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "<0.02."
Processing 00000000.tx.46: Therefore, we genotyped these three polymorphisms in 2,434 type 1 diabetic families of European descent. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "these three polymorphisms in 2,434 type 1 diabetic families"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0032529:polymorphisms [Genetic Function]
   706 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "of European descent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680043:descent [Family Group]
Processing 00000000.tx.47: Parental genotype frequencies were found to be consistent with Hardy-Weinberg equilibrium. 

Phrase: "Parental genotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "consistent with Hardy-Weinberg equilibrium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.48: TDT and conditional logistic regression analyses were performed, and the results are summarized in Table 1. 

Phrase: "TDT"

Phrase: "and"

Phrase: "conditional logistic regression analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   906   C0681925:logistic regression analysis [Research Activity]
   861   C0034980:Regression Analyses [Intellectual Product]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "summarized in Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.49: In this large dataset of type 1 diabetic families, we were unable to confirm the reported association of IRS1 (12), although we had >95% power to detect the reported effect (OR 2.5, P = 0.0008, minor allele frequency = 8%). 

Phrase: "In this large dataset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150098:Data Set [Intellectual Product]
   861   C1706233:Dataset [Intellectual Product]

Phrase: "of type 1 diabetic families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the reported association of IRS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "we"

Phrase: "had >"

Phrase: "95% power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the reported effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(OR 2.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "P = 0.0008,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "minor allele frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0017270:Allele Frequency [Quantitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "= 8%"

Phrase: ")."
Processing 00000000.tx.50: Similarly, the KCNJ11 Glu23Lys variant was not associated with type 1 diabetes, as a nonsignificant deviation from 50:50 transmission from heterozygous parents was observed. 

Phrase: "Similarly,"

Phrase: "the KCNJ11 Glu23Lys variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with type 1 diabetes,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "as"

Phrase: "a nonsignificant deviation from 50"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0012727:Deviation [Spatial Concept]
   760   C0205419:Deviation [Qualitative Concept]
   760   C1705236:Deviation [Finding]

Phrase: ":"

Phrase: "50 transmission from heterozygous parents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040722:transmission [Idea or Concept]
   760   C0242781:Transmission [Pathologic Function]
   760   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.51: View this table: [in this window] [in a new window]  TABLE 1 Type 1 diabetes SNP association analysis  The PPARG2 Pro12Ala SNP, however, showed some evidence of association with the more common Pro allele conferring risk to type 1 diabetes (relative risk [RR] 1.15, 95% CI 1.041.28, P = 0.008), as is the case for type 2 diabetes. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Type 1 diabetes SNP association analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "The PPARG2 Pro12Ala SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0752046:SNP [Nucleotide Sequence]
   793   C1527094:SNP [Conceptual Entity]

Phrase: "however,"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "some evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with the more common Pro allele conferring risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0035647:Risk [Qualitative Concept]

Phrase: "to type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(relative risk [RR] 1.15,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0242492:Relative Risk [Quantitative Concept]
   861   C0966318:RISK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0035647:Risk [Qualitative Concept]
   812   C0080103:Relative [Family Group]
   812   C0205345:Relative [Qualitative Concept]
   812   C1547039:*Relative [Quantitative Concept]

Phrase: "95% CI 1.041.28,"

Phrase: "P = 0.008"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "as is"

Phrase: "the case for type 2 diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0868928:Case [Functional Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.52: TDT results indicated a transmission to affected individuals of 54% (769 of 1,437 informative transmissions, P = 0.008). 

Phrase: "TDT results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "a transmission to affected individuals of 54%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0040722:transmission [Idea or Concept]
   748   C0242781:Transmission [Pathologic Function]
   748   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "(769 of 1,437 informative transmissions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C2986490:Informative [Qualitative Concept]
   719   C0040722:transmission [Idea or Concept]
   719   C0242781:Transmission [Pathologic Function]
   719   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "P = 0.008"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.53: To confirm that this result was not due to genotyping error, we regenotyped the PPARG2 Pro12Ala SNP on the reverse strand and obtained 99.77% concordance. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "this result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "was"

Phrase: "not due to genotyping error,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0743559:error [Qualitative Concept]
   760   C1285573:Genotyping [Laboratory Procedure]
   760   C1518422:Not [Functional Concept]
   760   C1608199:Error [Functional Concept]
   760   C3146286:Due [Idea or Concept]
   726 E C0017431:Genotype [Organism Attribute]

Phrase: "we regenotyped"

Phrase: "the PPARG2 Pro12Ala SNP on the reverse strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0752046:SNP [Nucleotide Sequence]
   735   C1527094:SNP [Conceptual Entity]

Phrase: "and"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "99.77% concordance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0680240:concordance [Social Behavior]
Processing 00000000.tx.54: In agreement with the reports in type 2 diabetes, the minor allele (G) is protective in type 1 diabetes. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with the reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "in type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "the minor allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "(G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "is"

Phrase: "protective in type 1 diabetes."
Processing 00000000.tx.55: Genotype RRs were calculated by conditional logistic regression analysis for the Pro12Ala SNP, giving values of 0.85 (0.760.95, P = 0.005) and 0.87 (0.611.24, P = 0.44) for the C/G and G/G genotypes, respectively, relative to the C/C genotype. 

Phrase: "Genotype RRs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1849334:RRS [Disease or Syndrome]

Phrase: "were"

Phrase: "calculated by conditional logistic regression analysis"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0681925:logistic regression analysis [Research Activity]
   790   C0034980:Regression Analysis [Intellectual Product]
   790   C0206031:Logistic Regression [Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0242415:logistic [Occupational Activity]
   753   C0444686:Calculated [Functional Concept]
   753   C0684320:Regression [Pathologic Function]
   753   C0684321:Regression [Mental Process]
   753   C0936012:Analysis [Research Activity]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1524024:analysis [Functional Concept]
   753   C1701901:Conditional [Qualitative Concept]
   753   C1963686:Conditional [Functional Concept]

Phrase: "for the Pro12Ala SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0752046:SNP [Nucleotide Sequence]
   861   C1527094:SNP [Conceptual Entity]

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "values of 0.85"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "(0.760.95,"

Phrase: "P = 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "0.87"

Phrase: "(0.611.24,"

Phrase: "P = 0.44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "for the C/G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "G/G genotypes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotypes [Organism Attribute]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "respectively,"

Phrase: "relative to the C/C genotype."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.56: Conversely, relative to the G/G genotype, the C/G and C/C genotypes have RRs of 0.98 (0.691.39) and 1.15 (0.811.64), respectively. 

Phrase: "Conversely,"

Phrase: "relative to the G/G genotype,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "the C/G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "C/C genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "have"

Phrase: "RRs of 0.98"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1849334:RRS [Disease or Syndrome]

Phrase: "(0.691.39"

Phrase: ")"

Phrase: "and"

Phrase: "1.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(0.811.64"

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.57: The nonsignificant result for the G/G genotype (and the risks relative to the G/G genotype) is likely a result of its low frequency. 

Phrase: "The nonsignificant result for the G/G genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "("

Phrase: "and"

Phrase: "the risks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risks [Qualitative Concept]

Phrase: "relative to the G/G genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "a result of its low frequency."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
Processing 00000000.tx.58: Our failure to replicate the Italian study (12), which reported an association between IRS1 Gly972Arg and type 1 diabetes, is perhaps not surprising given the modest sample size previously studied. 

Phrase: "Our failure to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "replicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "the Italian study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "an association between IRS1 Gly972Arg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "type 1 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "perhaps"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "surprising"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the modest sample size previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242618:Sample Size [Quantitative Concept]
   812   C0456389:size [Spatial Concept]

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.59: Nevertheless, we genotyped this SNP with two technologies, as family studies of rare variants may be compromised because apparent undertransmission of alleles can be observed due to genotyping errors. 

Phrase: "Nevertheless,"

Phrase: "we"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "this SNP with two technologies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0752046:SNP [Nucleotide Sequence]
   760   C1527094:SNP [Conceptual Entity]

Phrase: "as"

Phrase: "family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "studies of rare variants"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205419:variants [Qualitative Concept]
   770   C0521114:Rare [Temporal Concept]
   770   C0522498:Rare [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1514917:RARE [Gene or Genome]
   770   C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "be"

Phrase: "compromised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945640:compromise [Finding]

Phrase: "because"

Phrase: "apparent undertransmission of alleles"

Phrase: "can"

Phrase: "be"

Phrase: "observed due to genotyping errors."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0743559:errors [Qualitative Concept]
   760   C1285573:Genotyping [Laboratory Procedure]
   760   C1441672:Observed [Functional Concept]
   760   C3146286:Due [Idea or Concept]
   726 E C0017431:Genotype [Organism Attribute]
   726 E C1608199:Error [Functional Concept]
Processing 00000000.tx.60: A concordance rate of 99.74% was observed between genotypes generated by the two methods. 

Phrase: "A concordance rate of 99.74%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0680240:concordance [Social Behavior]
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "observed between genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017431:Genotypes [Organism Attribute]
   790   C1441672:Observed [Functional Concept]

Phrase: "generated by the two methods."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0205448:Two [Quantitative Concept]
   760   C0449851:Methods [Functional Concept]
   760   C3146294:Generated [Activity]
   726 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.61: It is unlikely that this common SNP could be genetically associated with type 1 diabetes in central Italy and not in other European countries. 

Phrase: "It"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "this common SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0752046:SNP [Nucleotide Sequence]
   861   C1527094:SNP [Conceptual Entity]

Phrase: "could"

Phrase: "be"

Phrase: "genetically"

Phrase: "associated with type 1 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in central Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022277:Italy [Geographic Area]

Phrase: "and"

Phrase: "not in other European countries."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0454713:European country [Geographic Area]
   760   C0239307:European [Population Group]
   760   C0454664:Countries [Geographic Area]
   760   C1518422:Not [Functional Concept]
   760   C1535514:European [Population Group]
Processing 00000000.tx.62: In these data we found no evidence of population heterogeneity (2 [4 df] = 1.93, P = 0.75, in five populations). 

Phrase: "In these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no evidence of population heterogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[4 df] = 1.93,"

Phrase: "P = 0.75,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "in five populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: ")."
Processing 00000000.tx.63: Hence, our study highlights the importance of large datasets to investigate the multigenic basis of type 1 diabetes, type 2 diabetes, and other common multifactorial diseases. 

Phrase: "Hence,"

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "highlights"

Phrase: "the importance of large datasets to"

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the multigenic basis of type 1 diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "other common multifactorial diseases."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.64: If the PPARG2 Pro12Ala association is confirmed in other studies, then a molecular link would be established between type 1 and 2 diabetes involving a protective effect of the minor allele (Ala). 

Phrase: "If"

Phrase: "the PPARG2 Pro12Ala association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0004083:Association [Mental Process]
   793   C0439849:Association [Qualitative Concept]
   793   C0596306:Association [Phenomenon or Process]
   793   C0699792:association [Social Behavior]

Phrase: "is"

Phrase: "confirmed in other studies,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0521093:confirmed [Qualitative Concept]
   770   C0750484:Confirmed [Idea or Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C1456348:Confirm [Qualitative Concept]
   737 E C2603343:Study [Research Activity]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "a molecular link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1517892:Link [Intellectual Product]
   861   C1704666:Link [Intellectual Product]

Phrase: "would"

Phrase: "be"

Phrase: "established between type 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0441729:Type 1 [Classification]
   770   C0332307:Type [Qualitative Concept]
   770   C0443211:Established [Qualitative Concept]
   770   C1272684:Established [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "a protective effect of the minor allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(Ala"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]
   907 E C0043189:Wing [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.65: Other studies have reported that thiazolidinediones possess anti-inflammatory properties and decrease diabetes incidence in nonobese diabetic (NOD) mice (22,23). 

Phrase: "Other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that thiazolidinediones"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "anti-inflammatory properties"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]
   734   C0003209:Anti-inflammatory [Pharmacologic Substance]
   734   C1515999:Anti-inflammatory [Qualitative Concept]

Phrase: "and"

Phrase: "decrease diabetes incidence in nonobese diabetic (NOD) mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021149:Incidence [Quantitative Concept]
   748   C0220856:incidence [Functional Concept]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.66: Prevention of autoimmune diabetes in NOD mice by thiazolidinediones has been associated with suppression of intercellular adhesion molecule 1 (ICAM1) expression and alteration of Th1/Th2 cytokine balance (24). 

Phrase: "Prevention of autoimmune diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1659987:diabetes prevention [Educational Activity]
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]

Phrase: "in NOD mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "by thiazolidinediones"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "associated with suppression of intercellular adhesion molecule 1 (ICAM1) expression"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   818   C0063695:Intercellular adhesion molecule 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1334074:INTERCELLULAR ADHESION MOLECULE 1 [Gene or Genome]
   790   C0242565:intercellular adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0001511:Adhesion [Pathologic Function]
   742   C0175633:Adhesion [Natural Phenomenon or Process]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0567416:Molecule [Substance]
   742   C0728721:suppression [Mental Process]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "alteration of Th1/Th2 cytokine balance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1515926:Alteration [Idea or Concept]
   716   C2936375:Th1-Th2 Cytokine Balance [Organism Function]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.67: Interestingly, we have recently reported (25) an association of the Gly241Arg polymorphism of ICAM1 with type 1 diabetes. 

Phrase: "Interestingly,"

Phrase: "we"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(25"

Phrase: ")"

Phrase: "an association of the Gly241Arg polymorphism of ICAM1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0004083:Association [Mental Process]
   738   C0439849:Association [Qualitative Concept]
   738   C0596306:Association [Phenomenon or Process]
   738   C0699792:association [Social Behavior]

Phrase: "with type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.68: It is possible that PPAR agonists may be worth testing in prevention of immune rejection of transplanted islets.  

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that PPAR agonists"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0243192:agonists [Pharmacologic Substance]
   804   C2987634:agonists [Pharmacologic Substance]
   771   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   771   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "may"

Phrase: "be worth testing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0039593:Testing [Functional Concept]
   790   C0392366:testing [Intellectual Product]
   790   C2987476:Be [Conceptual Entity]

Phrase: "in prevention"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199176:Prevention [Therapeutic or Preventive Procedure]
  1000   C1706420:PREVENTION [Research Activity]
  1000   C2700409:prevention [Qualitative Concept]

Phrase: "of immune rejection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035015:Rejection [Social Behavior]
   861   C1548437:Rejection [Idea or Concept]
   861   C1882923:REJECTION [Phenomenon or Process]
   861   C2700401:Rejection [Activity]

Phrase: "of transplanted islets."
Processing 00000000.tx.69: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS REFERENCES  All families were Caucasian of European descent and were composed of two parents and at least one affected child. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "All families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "were"

Phrase: "Caucasian of European descent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007457:Caucasian [Population Group]
   770   C0043157:Caucasian [Population Group]

Phrase: "and"

Phrase: "were"

Phrase: "composed of two parents"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0030551:Parents [Family Group]
   770   C0205448:Two [Quantitative Concept]
   737 E C2699423:Parent [Conceptual Entity]

Phrase: "and at least one affected child."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0008059:Child [Age Group]
   753   C0205447:One [Quantitative Concept]
   753   C0392760:Affected [Functional Concept]
   753   C0680063:CHILD [Family Group]
   753   C1314939:Affected [Functional Concept]
   753   C1515981:And [Idea or Concept]
Processing 00000000.tx.70: The families comprised up to 458 Diabetes U.K. 

Phrase: "The families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "comprised up to 458 Diabetes U.K."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1708601:K' [Quantitative Concept]
   714   C2700400:Comprise [Activity]
Processing 00000000.tx.71: Warren 1 multiplex from the U.K. 

Phrase: "Warren 1 multiplex from the U.K."
Processing 00000000.tx.72: (26), 328 U.S. multiplex from the Human Biological Data Interchange (27), 80 Yorkshire simplex from the U.K., 250 Belfast multiplex/simplex (28) from the U.K., 159 Norwegian simplex, 233 Romanian simplex, and 926 Finnish multiplex/simplex (29). 

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "328 U.S. multiplex from the Human Biological Data Interchange"

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "80 Yorkshire simplex from the U.K.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2338991:Simplex [Body Part, Organ, or Organ Component]

Phrase: "250 Belfast multiplex/simplex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2338991:Simplex [Body Part, Organ, or Organ Component]

Phrase: "(28"

Phrase: ")"

Phrase: "from the U.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "159 Norwegian simplex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2338991:Simplex [Body Part, Organ, or Organ Component]

Phrase: "233 Romanian simplex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2338991:Simplex [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "926 Finnish multiplex/simplex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2338991:Simplex [Body Part, Organ, or Organ Component]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.73: All DNA samples were collected with appropriate ethical approval and informed consent. 

Phrase: "All DNA samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected with appropriate ethical approval"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0026531:ethical [Idea or Concept]
   760   C0205540:Approval [Qualitative Concept]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C1548787:Appropriate [Qualitative Concept]
   760   C2346845:Approval [Intellectual Product]

Phrase: "and"

Phrase: "informed consent."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0021430:Informed Consent [Regulation or Law]
   861   C1511481:Consent [Functional Concept]
   861   C1522154:Informed [Qualitative Concept]
   861   C1554192:consent [Idea or Concept]
   827 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827 E C0700287:inform [Health Care Activity]
   827 E C1552002:inform [Idea or Concept]
Processing 00000000.tx.74: Genotyping. 

Phrase: "Genotyping."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285573:Genotyping [Laboratory Procedure]
Processing 00000000.tx.75: SNPs were genotyped by the TaqMan 5' nuclease assay according to the manufacturers instructions (Applied Biosystems, Warrington, U.K.). 

Phrase: "SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "genotyped by the TaqMan 5' nuclease assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C0597094:nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1510438:Assay [Laboratory Procedure]
   714   C0017431:Genotype [Organism Attribute]

Phrase: "according to the manufacturers instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "(Applied Biosystems,"

Phrase: "Warrington,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.76: TaqMan primers and probes were designed by Applied Biosystems. 

Phrase: "TaqMan primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "designed by Applied Biosystems."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0185125:Applied [Health Care Activity]
   737   C1707689:Design [Activity]
   737   C2983265:DESIGN [Intellectual Product]
Processing 00000000.tx.77: The PPARG2 Pro12Ala SNP was independently typed by the TaqMan 5' nuclease assay on both strands. 

Phrase: "The PPARG2 Pro12Ala SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0752046:SNP [Nucleotide Sequence]
   793   C1527094:SNP [Conceptual Entity]

Phrase: "was"

Phrase: "independently"

Phrase: "typed by the TaqMan 5' nuclease assay"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0457499:Type 5 [Intellectual Product]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C0597094:nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1510438:Assay [Laboratory Procedure]
   714   C0332307:Type [Qualitative Concept]
   714   C1547052:*Type [Quantitative Concept]

Phrase: "on both strands."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1704972:Strand [Spatial Concept]
   966   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.78: IRS1 Gly972 Arg was also genotyped by restriction enzyme digest with XmaI, incorrectly reported as MvaI in Federici et al. 

Phrase: "IRS1 Gly972 Arg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "genotyped by restriction enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0014442:Enzyme [Enzyme,Organic Chemical]
   770   C0443288:Restriction [Functional Concept]
   737   C0017431:Genotype [Organism Attribute]

Phrase: "digest with XmaI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digest [Physiologic Function]

Phrase: "incorrectly"

Phrase: "reported as MvaI"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "in Federici et al."
Processing 00000000.tx.79: (12). 

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.80: All genotyping data were double scored to minimize error. 

Phrase: "All genotyping data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "scored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:scored [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "error."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0743559:error [Qualitative Concept]
  1000   C1608199:Error [Functional Concept]
Processing 00000000.tx.81: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.82: All statistical analyses were performed in Stata (http://www.stata.com) using the Genassoc package (http://www-gene.cimr.cam.ac.uk/clayton/software/stata). 

Phrase: "All statistical analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed in Stata"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.stata.com)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Genassoc package"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013194:Package [Medical Device]
   861   C2700580:Package [Manufactured Object]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www-gene.cimr.cam.ac.uk/clayton/software/stata"

Phrase: ")."
Processing 00000000.tx.83: A modified test was used to evaluate Hardy-Weinberg equilibrium that allows for allelic frequencies to differ between known population groups. 

Phrase: "A modified test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "Hardy-Weinberg equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014653:Equilibrium [Organism Function]
   827   C1547026:Equilibrium [Quantitative Concept]

Phrase: "that"

Phrase: "allows for allelic frequencies to"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0017270:allelic frequency [Quantitative Concept]
   760   C0439603:Frequencies [Temporal Concept]
   760   C0683607:allow [Social Behavior]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "differ between known population groups."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C1257890:Population Group [Population Group]
           Group
           Population
   760   C0032659:Population [Quantitative Concept]
   760   C0205309:Known [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
Processing 00000000.tx.84: Allelic association was tested using the TDT. 

Phrase: "Allelic association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TDT."
Processing 00000000.tx.85: Pseudo-control subjects, generated by conditioning on parental genotype, allowed us to test genotypic association with conditional logistic regression (30). 

Phrase: "Pseudo-control subjects,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "generated by conditioning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0009647:Conditioning [Mental Process]
   790   C3146294:Generated [Activity]

Phrase: "on parental genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "genotypic association with conditional logistic regression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.86: This also allowed us to test for population heterogeneity by adding appropriate interaction terms into the regression equation. 

Phrase: "This also"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for population heterogeneity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0086833:Population Heterogeneity [Group Attribute]
   770   C0019409:Heterogeneity [Qualitative Concept]
   770   C0022885:Test [Laboratory Procedure]
   770   C0032659:Population [Quantitative Concept]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   770   C1257890:Population [Population Group]

Phrase: "by adding appropriate interaction terms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1704675:Interaction [Functional Concept]
   779   C1515273:Term [Temporal Concept]
   779   C1705313:Term [Idea or Concept]
   779   C2826302:TERM [Intellectual Product]

Phrase: "into the regression equation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0552449:Equation [Conceptual Entity]
Processing 00000000.tx.87: Robust variance estimates were used for the calculation of P values and 95% CIs in order to correct for nonindependence of transmissions within families with more than one affected offspring. 

Phrase: "Robust variance estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0750572:estimates [Quantitative Concept]

Phrase: "were"

Phrase: "used for the calculation of P values"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   757   C1524063:Use of [Functional Concept]
   748   C0042295:Values [Qualitative Concept]
   748   C1273517:used [Finding]
   748   C1441506:Calculation [Activity]
   745   C1709380:P-Value [Quantitative Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1522609:Value [Quantitative Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "95% CIs in order"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1504308:Cis [Eukaryote]

Phrase: "to correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "for nonindependence"

Phrase: "of transmissions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0040722:transmission [Idea or Concept]
   966   C0242781:Transmission [Pathologic Function]
   966   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "within families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "than one affected offspring."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0680063:Offspring [Family Group]
Processing 00000000.tx.88: As a quality control measure, the transmission of PPARG2 Pro12Ala alleles to unaffected offspring was evaluated by TDT and found to be nonsignificant (data not shown), ruling out genotyping error as a possible explanation for the association observed with type 1 diabetes.  

Phrase: "As a quality control measure,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0079809:Measure [Quantitative Concept]
   827   C0242485:Measure [Functional Concept]
   734   C0034378:quality control [Functional Concept]
   734   C1561524:Quality Control [Intellectual Product]
   734   C1610034:Quality Control [Intellectual Product]

Phrase: "the transmission of PPARG2 Pro12Ala alleles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0040722:transmission [Idea or Concept]
   738   C0242781:Transmission [Pathologic Function]
   738   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "to unaffected offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Offspring [Family Group]

Phrase: "was"

Phrase: "evaluated by TDT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0220825:Evaluated [Functional Concept]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "nonsignificant"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "ruling"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruling [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "genotyping"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1285573:Genotyping [Laboratory Procedure]
   966 E C0017431:Genotype [Organism Attribute]

Phrase: "error as a possible explanation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0743559:error [Qualitative Concept]
   760   C1608199:Error [Functional Concept]

Phrase: "for the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "observed with type 1 diabetes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.89: ACKNOWLEDGMENTS  We thank the Juvenile Diabetes Research Foundation and the Wellcome Trust for financial support. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the Juvenile Diabetes Research Foundation"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   819   C2986512:Research Base [Organization]
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "the Wellcome Trust for financial support."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237935:Trust [Individual Behavior]
   753   C3245466:trust [Idea or Concept]
Processing 00000000.tx.90: We also thank the Human Biological Data Interchange and Diabetes U.K. for U.S. and U.K. multiplex families, respectively, the Norwegian Study Group for Childhood Diabetes for sample collection of Norwegian samples, Sarah Field and Tasneem Hassanali for DNA preparation, and David Clayton, Jason Cooper, and Chris Lowe for discussions. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the Human Biological Data Interchange"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0596723:human data [Intellectual Product,Research Activity]

Phrase: "and"

Phrase: "Diabetes U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "for U.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:U S [Geographic Area]

Phrase: "and"

Phrase: "U.K. multiplex families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]

Phrase: "respectively,"

Phrase: "the Norwegian Study Group for Childhood Diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0441833:Group [Idea or Concept]
   748   C0557651:Study [Manufactured Object]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C2603343:Study [Research Activity]

Phrase: "for sample collection"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0200345:sample collection [Laboratory Procedure]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   789 E C1516695:Collected [Idea or Concept]

Phrase: "of Norwegian samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "Sarah Field"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   861   C1521738:Field [Conceptual Entity]
   861   C2346620:Field [Conceptual Entity]
   861   C2349184:Field [Conceptual Entity]
   861   C3539073:FIELD [Spatial Concept]

Phrase: "and"

Phrase: "Tasneem Hassanali for DNA preparation,"

Phrase: "and"

Phrase: "David Clayton,"

Phrase: "Jason Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0335912:Cooper [Professional or Occupational Group]

Phrase: "and"

Phrase: "Chris Lowe for discussions."
Processing 00000000.tx.91: Address correspondence and reprint requests to John A. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0686900:request [Functional Concept]
  1000   C1272683:Request [Functional Concept]
  1000   C1522634:Request [Intellectual Product]

Phrase: "to John"

Phrase: "A."
Processing 00000000.tx.92: Todd, JDRF/WT Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Hills Rd., Cambridge CB2 2XY, U.K. 

Phrase: "Todd,"

Phrase: "JDRF/WT Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Inflammation Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Cambridge Institute for Medical Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0035172:Research Institute [Organization]
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Wellcome Trust/MRC Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1547706:Building [Functional Concept]
   812   C1999269:Building [Manufactured Object]

Phrase: "Hills Rd.,"

Phrase: "Cambridge CB2 2XY,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.93: E-mail: john.todd{at}cimr.cam.ac.uk Received for publication October 3, 2003 and accepted in revised form October 31, 2003 ICAM1, intercellular adhesion molecule 1; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "john.todd{at}cimr.cam.ac.uk"

Phrase: "Received for publication October 3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2003"

Phrase: "and"

Phrase: "accepted in revised form October 31,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C0450355:31 [Intellectual Product]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2003 ICAM1,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0063695:Intercellular adhesion molecule 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   937   C1334074:INTERCELLULAR ADHESION MOLECULE 1 [Gene or Genome]
   884   C0242565:intercellular adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001511:Adhesion [Pathologic Function]
   804   C0175633:Adhesion [Natural Phenomenon or Process]
   804   C0567416:Molecule [Substance]
   733 E C1521991:Molecular [Qualitative Concept]

Phrase: "intercellular adhesion molecule 1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0063695:Intercellular adhesion molecule 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334074:INTERCELLULAR ADHESION MOLECULE 1 [Gene or Genome]
   923   C0242565:intercellular adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
   812   C0567416:Molecule [Substance]
   741 E C1521991:Molecular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.94: IRS1, insulin receptor substrate 1; 

Phrase: "IRS1,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin receptor substrate 1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.95: KCNJ11, potassium inwardly rectifying channel gene; 

Phrase: "KCNJ11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:KCNJ11 [Gene or Genome]

Phrase: "potassium inwardly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032821:Potassium [Element, Ion, or Isotope]
   861   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "rectifying"

Phrase: "channel gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.96: PPAR, peroxisome proliferator-activated receptor ; PPARG2, peroxisome proliferator-activated receptor 2 gene; 

Phrase: "PPAR,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "peroxisome proliferator-activated receptor"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "; PPARG2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C1335671:Receptor Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]

Phrase: "peroxisome proliferator-activated receptor 2 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C1335671:Receptor Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]
   734   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.97: SNP, single nucleotide polymorphism; 

Phrase: "SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "single nucleotide polymorphism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.98: TDT, transmission/disequilibrium test  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS REFERENCES  Donath MY, Storling J, Maedler K, Mandrup-Poulsen T: Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. 

Phrase: "TDT,"

Phrase: "transmission/disequilibrium test"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0040722:transmission [Idea or Concept]
   827   C0242781:Transmission [Pathologic Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0392366:test [Intellectual Product]
   827   C0394006:Disequilibrium [Disease or Syndrome]
   827   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Donath"

Phrase: "MY,"

Phrase: "Storling J,"

Phrase: "Maedler K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mandrup-Poulsen T"

Phrase: ":"

Phrase: "Inflammatory mediators"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   861   C0333348:Inflammatory [Functional Concept]
   827 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "islet beta-cell failure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]
   708   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   708   C1522529:Islet Cell [Cell]

Phrase: ":"

Phrase: "a link between type 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.99: J Mol Med81 :455 470,2003[Medline] Mathis D, Vence L, Benoist C: Beta-cell death during progression to diabetes. 

Phrase: "J Mol Med81"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346604:J/mol [Quantitative Concept]

Phrase: ":"

Phrase: "455 470,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mathis D,"

Phrase: "Vence L,"

Phrase: "Benoist C"

Phrase: ":"

Phrase: "Beta-cell death during progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0007587:Cell Death [Cell Function]
   760   C0011065:Death [Organism Function]
   760   C1306577:Death, NOS [Finding]

Phrase: "to diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.100: Nature414 :792 798,2001[Medline] Wilkin TJ: The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. 

Phrase: "Nature414"

Phrase: ":"

Phrase: "792 798,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wilkin TJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: ":"

Phrase: "The accelerator hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: ":"

Phrase: "weight gain as the missing link"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0043094:Weight Gain [Finding]
   790   C2911647:Weight gain [Finding]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1517378:Gain [Quantitative Concept]
   753   C1705104:Weight [Idea or Concept]
   748 E C0231246:weight gaining [Sign or Symptom]

Phrase: "between type I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441729:Type I [Classification]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "type II diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type II [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.101: Diabetologia44 :914 922,2001[Medline] Greenbaum CJ, Prigeon RL, DAlessio DA: Impaired -cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. 

Phrase: "Diabetologia44"

Phrase: ":"

Phrase: "914 922,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Greenbaum CJ,"

Phrase: "Prigeon RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "DAlessio DA"

Phrase: ":"

Phrase: "Impaired -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "cell function,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "incretin effect,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3179504:Incretin Effect [Physiologic Function]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "glucagon suppression in patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0221103:Suppression [Pathologic Function]
   770   C0301625:Suppression [Organism Function]
   770   C0439181:% suppression [Quantitative Concept]
   770   C0728721:suppression [Mental Process]

Phrase: "with type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "who"

Phrase: "have"

Phrase: "normal fasting glucose."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0860800:normal glucose [Finding]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]
Processing 00000000.tx.102: Diabetes51 :951 957,2002[Abstract/Free FullText] Dahlquist G, Blom L, Tuvemo T, Nystrom L, Sandstrom A, Wall S: The Swedish childhood diabetes study: results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "951 957,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dahlquist G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Blom L,"

Phrase: "Tuvemo T,"

Phrase: "Nystrom L,"

Phrase: "Sandstrom A,"

Phrase: "Wall S"

Phrase: ":"

Phrase: "The Swedish childhood diabetes study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "results from a nine year case register"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "and"

Phrase: "a one year case-referent study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0007328:Study, Case-Referent [Research Activity]
   853   C0085973:Case Study [Intellectual Product]
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]

Phrase: "indicating"

Phrase: "that type 1 (insulin-dependent) diabetes mellitus"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   913   C0011854:Diabetes Mellitus, Type 1 [Disease or Syndrome]
           Diabetes Mellitus, Insulin-Dependent
           Type 1 diabetes
           Insulin Dependent Diabetes
   876   C1320657:type diabetes [Finding]
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0441729:Type 1 [Classification]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0332307:Type [Qualitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1547052:*Type [Quantitative Concept]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1701901:Dependent [Qualitative Concept]
   799   C3244310:dependent [Functional Concept]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "associated with both type 2"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(non-insulin-dependent) diabetes mellitus"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "autoimmune disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004364:Autoimmune disorders [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.103: Diabetologia32 :2 6,1989[Medline] Li H, Lindholm E, Almgren P, Gustafsson A, Forsblom C, Groop L, Tuomi T: Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 diabetes. 

Phrase: "Diabetologia32"

Phrase: ":"

Phrase: "2 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lindholm E,"

Phrase: "Almgren P,"

Phrase: "Gustafsson A,"

Phrase: "Forsblom C,"

Phrase: "Groop L,"

Phrase: "Tuomi T"

Phrase: ":"

Phrase: "Possible human leukocyte antigen-mediated genetic interaction between type 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.104: J Clin Endocrinol Metab86 :574 582,2001[Abstract/Free FullText] Tuomilehto-Wolf E, Tuomilehto J, Hitman GA, Nissinen A, Stengard J, Pekkanen J, Kivinen P, Kaarsalo E, Karvonen MJ: Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region. 

Phrase: "J Clin Endocrinol Metab86"

Phrase: ":"

Phrase: "574 582,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tuomilehto-Wolf E,"

Phrase: "Tuomilehto J,"

Phrase: "Hitman GA,"

Phrase: "Nissinen A,"

Phrase: "Stengard J,"

Phrase: "Pekkanen J,"

Phrase: "Kivinen P,"

Phrase: "Kaarsalo E,"

Phrase: "Karvonen MJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: ":"

Phrase: "Genetic susceptibility to non-insulin dependent diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0314657:Genetic Susceptibility [Organism Attribute]
   744   C0012655:Susceptibility [Clinical Attribute]
   744   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   744   C0220898:Susceptibility [Organism Attribute]
   744   C0314603:Genetic [Functional Concept]
   744   C1264642:Susceptibility [Functional Concept]
   744   C1547045:*Susceptibility [Quantitative Concept]
   731   C2827756:Non Susceptible [Laboratory or Test Result]
   703   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   703   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]

Phrase: "and"

Phrase: "glucose intolerance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0271650:Glucose Intolerance [Disease or Syndrome]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0231199:Intolerance [Organism Function]
   861   C1744706:intolerance [Intellectual Product]
   861   C2355652:Intolerance [Organism Attribute]
   789 E C0231200:Intolerant [Functional Concept]

Phrase: "are"

Phrase: "located in HLA region."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
Processing 00000000.tx.105: BMJ307 :155 159,1993[Medline] Bennett ST, Todd JA: Human type 1 diabetes and the insulin gene: principles of mapping polygenes. 

Phrase: "BMJ307"

Phrase: ":"

Phrase: "155 159,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bennett ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Todd JA"

Phrase: ":"

Phrase: "Human type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0011854:Type 1 diabetes [Disease or Syndrome]
   875   C1320657:type diabetes [Finding]
   861   C0441729:Type 1 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "the insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "principles of mapping polygenes."
Processing 00000000.tx.106: Annu Rev Genet30 :343 370,1996[Medline] Florez JC, Hirschhorn J, Altshuler D: The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. 

Phrase: "Annu Rev Genet30"

Phrase: ":"

Phrase: "343 370,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Florez JC,"

Phrase: "Hirschhorn J,"

Phrase: "Altshuler D"

Phrase: ":"

Phrase: "The inherited basis of diabetes mellitus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: ":"

Phrase: "implications for the genetic analysis of complex traits."
Processing 00000000.tx.107: Ann Rev Genomics Hum Genet4 :257 291,2003 Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, Walker M, Levy JC, Sampson M, Halford S, McCarthy MI, Hattersley AT, Frayling TM: Large-scale association studies of variants in genes encoding the pancreatic -cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. 

Phrase: "Ann Rev Genomics Hum Genet4"

Phrase: ":"

Phrase: "257 291,"

Phrase: "2003 Gloyn AL,"

Phrase: "Weedon MN,"

Phrase: "Owen KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Turner MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Knight BA,"

Phrase: "Hitman G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Walker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Levy JC,"

Phrase: "Sampson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Halford S,"

Phrase: "McCarthy MI,"

Phrase: "Hattersley AT,"

Phrase: "Frayling TM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: ":"

Phrase: "Large-scale association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "studies of variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205419:variants [Qualitative Concept]
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]

Phrase: "in genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the pancreatic -cell KATP channel subunits Kir6.2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   818   C1416578:Kir6.2 [Gene or Genome]
   795   C0007634:Cell [Cell]
   795   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   795   C0439799:Channel [Spatial Concept]
   795   C1269647:Cell [Cell]
   795   C1704653:Cell [Medical Device]
   795   C1706095:Channel [Conceptual Entity]
   795   C1948049:Cell [Spatial Concept]
   762   C1711351:Subunit [Quantitative Concept]

Phrase: "(KCNJ11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:KCNJ11 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "SUR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412082:SUR1 [Gene or Genome]

Phrase: "(ABCC8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412082:ABCC8 [Gene or Genome]

Phrase: ")"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the KCNJ11 E23K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "is"

Phrase: "associated with type 2 diabetes."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.108: Diabetes52 :568 572,2003[Abstract/Free FullText] Dahlman I, Eaves IA, Kosoy R, Morrison VA, Heward J, Gough SC, Allahabadia A, Franklyn JA, Tuomilehto J, Tuomilehto-Wolf E, Cucca F, Guja C, Ionescu-Tirgoviste C, Stevens H, Carr P, Nutland S, McKinney P, Shield JP, Wang W, Cordell HJ, Walker N, Todd JA, Concannon P: Parameters for reliable results in genetic association studies in common disease. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "568 572,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dahlman I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Eaves IA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: "Kosoy R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Morrison VA,"

Phrase: "Heward J,"

Phrase: "Gough SC,"

Phrase: "Allahabadia A,"

Phrase: "Franklyn JA,"

Phrase: "Tuomilehto J,"

Phrase: "Tuomilehto-Wolf E,"

Phrase: "Cucca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Guja C,"

Phrase: "Ionescu-Tirgoviste C,"

Phrase: "Stevens H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Carr P,"

Phrase: "Nutland S,"

Phrase: "McKinney P,"

Phrase: "Shield JP,"

Phrase: "Wang W,"

Phrase: "Cordell HJ,"

Phrase: "Walker N,"

Phrase: "Todd JA,"

Phrase: "Concannon P"

Phrase: ":"

Phrase: "Parameters for reliable results"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0449381:Parameters [Finding]
   737 E C0549193:Parameter [Spatial Concept]
   737 E C1704769:Parameter [Conceptual Entity]
   737 E C2350001:Parameter [Quantitative Concept]

Phrase: "in genetic association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "studies in common disease."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205214:Common [Quantitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1522138:Common [Functional Concept]
   770   C2603343:Study [Research Activity]
   770   C3245511:common [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.109: Nat Genet30 :149 150,2002[Medline] Federici M, Petrone A, Porzio O, Bizzarri C, Lauro D, DAlfonso R, Patera I, Cappa M, Nistico L, Baroni M, Sesti G, di Mario U, Lauro R, Buzzetti R: The Gly972Arg IRS-1 variant is associated with type 1 diabetes in continental Italy. 

Phrase: "Nat Genet30"

Phrase: ":"

Phrase: "149 150,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Federici M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Petrone A,"

Phrase: "Porzio O,"

Phrase: "Bizzarri C,"

Phrase: "Lauro D,"

Phrase: "DAlfonso R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Patera I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Cappa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nistico L,"

Phrase: "Baroni M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sesti G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "di Mario U,"

Phrase: "Lauro R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Buzzetti R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "The Gly972Arg IRS-1 variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:Variant [Qualitative Concept]

Phrase: "is"

Phrase: "associated with type 1 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in continental Italy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022277:Italy [Geographic Area]
Processing 00000000.tx.110: Diabetes52 :887 890,2003[Abstract/Free FullText] Lee CH, Olson P, Evans RM: Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "887 890,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Olson P,"

Phrase: "Evans RM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: ":"

Phrase: "Minireview"

Phrase: ":"

Phrase: "lipid metabolism,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "metabolic diseases,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0025517:Metabolic Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "peroxisome proliferator-activated receptors."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0166418:Peroxisome Proliferator-Activated Receptors [Amino Acid, Peptide, or Protein,Receptor]
   988 E C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.111: Endocrinology144 :2201 2207,2003[Abstract/Free FullText] Spiegelman BM: PPAR-: adipogenic regulator and thiazolidinedione receptor. 

Phrase: "Endocrinology144"

Phrase: ":"

Phrase: "2201 2207,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Spiegelman BM"

Phrase: ":"

Phrase: "PPAR-"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: ":"

Phrase: "adipogenic regulator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0182953:REGULATOR [Medical Device]
   861   C1704734:Regulator [Medical Device]
   861   C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "thiazolidinedione receptor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0166417:Thiazolidinedione Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.112: Diabetes47 :507 514,1998[Abstract] Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J: A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. 

Phrase: "Diabetes47"

Phrase: ":"

Phrase: "507 514,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450381:507 [Intellectual Product]

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Deeb SS,"

Phrase: "Fajas L,"

Phrase: "Nemoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pihlajamaki J,"

Phrase: "Mykkanen L,"

Phrase: "Kuusisto J,"

Phrase: "Laakso M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fujimoto W,"

Phrase: "Auwerx J"

Phrase: ":"

Phrase: "A Pro12Ala substitution in PPARgamma2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1555721:Substitution [Idea or Concept]
   760   C1706204:Substitution [Activity]

Phrase: "associated with decreased receptor activity,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1152633:receptor activity [Molecular Function]
   797   C0086439:Decreased activity [Sign or Symptom]
   760   C0205177:Activity [Functional Concept]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0442797:decreased [Qualitative Concept]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1561536:*Activity [Idea or Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "body mass index"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0005893:Body Mass Index [Diagnostic Procedure]
  1000   C1305855:Body mass index [Clinical Attribute]
   901   C0518010:body mass [Finding]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0577559:Mass [Finding]
   827   C0918012:Index [Intellectual Product]
   827   C1268086:Body [Anatomical Structure]
   827   C1306372:*Mass [Quantitative Concept]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "improved insulin sensitivity."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   901   C0920563:Insulin Sensitivity [Pathologic Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036667:Sensitivity [Quantitative Concept]
   827   C0312418:Sensitivity [Mental Process]
   827   C0427965:Sensitivity [Finding]
   827   C1511883:Sensitivity [Quantitative Concept]
   827   C1522640:Sensitivity [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C2346484:SENSITIVITY [Phenomenon or Process]
   827   C2349185:Sensitivity [Qualitative Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332324:Sensitive [Functional Concept]
   755 E C1550474:sensitive [Idea or Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.113: Nat Genet20 :284 287,1998[Medline] Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC: Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with type 2 diabetes mellitus (UKPDS 53). 

Phrase: "Nat Genet20"

Phrase: ":"

Phrase: "284 287,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gloyn AL,"

Phrase: "Hashim Y,"

Phrase: "Ashcroft SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Ashfield R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wiltshire S,"

Phrase: "Turner RC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: ":"

Phrase: "Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "studies of variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205419:variants [Qualitative Concept]
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]

Phrase: "in promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "coding regions of beta-cell ATP-sensitive K-channel genes SUR1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   738   C0009219:Coding [Occupational Activity]
   737   C1268228:Cell region [Cell Component]
   722   C0079941:Coding Region [Gene or Genome]
   704   C0017446:Region [Geographic Area]
   704   C0205147:Region [Spatial Concept]
   704 E C0805701:Code [Intellectual Product]

Phrase: "and"

Phrase: "Kir6.2 with type 2 diabetes mellitus"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   853   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Diabetes mellitus type 2
           Type 2 Diabetes
           Diabetes Type 2
   853   C2984301:Type II diabetes mellitus [Functional Concept]
   778   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   778   C1416578:Kir6.2 [Gene or Genome]
   774   C0441730:Type 2 [Classification]
   774   C1320657:Diabetes type [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "(UKPDS 53"

Phrase: ")."
Processing 00000000.tx.114: Diabet Med18 :206 212,2001[Medline] Hani EH, Boutin P, Durand E, Inoue H, Permutt MA, Velho G, Froguel P: Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. 

Phrase: "Diabet Med18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1537679:MED18 [Gene or Genome]

Phrase: ":"

Phrase: "206 212,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hani EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Boutin P,"

Phrase: "Durand E,"

Phrase: "Inoue H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Permutt MA,"

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Froguel P"

Phrase: ":"

Phrase: "Missense mutations in the pancreatic islet beta cell inwardly"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C0599155:Mutations, Missense [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "rectifying"

Phrase: "K+ channel gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "(KIR6.2/BIR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1416578:BIR [Gene or Genome]
           Kir6.2
   827   C3272365:BIR [Genetic Function]

Phrase: ")"

Phrase: ":"

Phrase: "a meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role in the polygenic basis of type II diabetes mellitus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "in Caucasians."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007457:Caucasians [Population Group]
  1000   C0043157:Caucasians [Population Group]
Processing 00000000.tx.115: Diabetologia41 :1511 1515,1998[Medline] Schwanstecher C, Meyer U, Schwanstecher M: K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic -cell ATP-sensitive K+ channels. 

Phrase: "Diabetologia41"

Phrase: ":"

Phrase: "1511 1515,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schwanstecher C,"

Phrase: "Meyer U,"

Phrase: "Schwanstecher M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "K(IR)6.2 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0032529:Polymorphism [Genetic Function]
   804   C1882417:Polymorphism [Qualitative Concept]

Phrase: "predisposes to type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "by inducing overactivity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0474395:overactivity [Finding]
   861   C1536696:Overactivity [Finding]
   789 E C0443272:Overactive [Qualitative Concept]

Phrase: "of pancreatic -cell ATP-sensitive K+ channels."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0332324:Sensitive [Functional Concept]
   799   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   799   C1550474:sensitive [Idea or Concept]
   799   C1708601:K' [Quantitative Concept]
   766   C0439799:Channel [Spatial Concept]
   766   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.116: Diabetes51 :875 879,2002[Abstract/Free FullText] Palmer JP: Beta cell rest and recovery: does it bring patients with latent autoimmune diabetes in adults to euglycemia? 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "875 879,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Palmer JP"

Phrase: ":"

Phrase: "Beta cell rest"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035253:Rest [Daily or Recreational Activity]
   827   C1622890:ResT [Molecular Function]
   734   C0030281:Beta cell [Cell]

Phrase: "and"

Phrase: "recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: ":"

Phrase: "does"

Phrase: "it"

Phrase: "bring"

Phrase: "patients with latent autoimmune diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "in adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "to euglycemia?"
Processing 00000000.tx.117: Ann N Y Acad Sci958 :89 98,2002[Abstract/Free FullText] Burks DJ, White MF: IRS proteins and -cell function. 

Phrase: "Ann N Y Acad Sci958"

Phrase: ":"

Phrase: "89 98,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Burks DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "White MF"

Phrase: ":"

Phrase: "IRS proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "cell function."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.118: Diabetes50 (Suppl. 1) :S140 S145,2001[Medline] Jellema A, Zeegers MP, Feskens EJ, Dagnelie PC, Mensink RP: Gly972Arg variant in the insulin receptor substrate-1 gene and association with type 2 diabetes: a meta-analysis of 27 studies. 

Phrase: "Diabetes50"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "S140 S145,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jellema A,"

Phrase: "Zeegers MP,"

Phrase: "Feskens EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Dagnelie PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Mensink RP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: ":"

Phrase: "Gly972Arg variant in the insulin receptor substrate-1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:Variant [Qualitative Concept]

Phrase: "and"

Phrase: "association with type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C3645563:Association type [Intellectual Product]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: ":"

Phrase: "a meta-analysis of 27 studies."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.119: Diabetologia46 :990 995,2003[Medline] Beales PE, Liddi R, Giorgini AE, Signore A, Procaccini E, Batchelor K, Pozzilli P: Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse. 

Phrase: "Diabetologia46"

Phrase: ":"

Phrase: "990 995,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Beales PE,"

Phrase: "Liddi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Giorgini AE,"

Phrase: "Signore A,"

Phrase: "Procaccini E,"

Phrase: "Batchelor K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Pozzilli P"

Phrase: ":"

Phrase: "Troglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "insulin dependent diabetes in the non-obese diabetic mouse."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   810   C0011860:Non-Insulin Dependent Diabetes [Disease or Syndrome]
   790   C0011854:Insulin Dependent Diabetes [Disease or Syndrome]
   762   C0421248:diabetic insulin [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1701901:Dependent [Qualitative Concept]
   742   C3244310:dependent [Functional Concept]
Processing 00000000.tx.120: Eur J Pharmacol357 :221 225,1998[Medline] Beales PE, Pozzilli P: Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. 

Phrase: "Eur J Pharmacol357"

Phrase: ":"

Phrase: "221 225,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Beales PE,"

Phrase: "Pozzilli P"

Phrase: ":"

Phrase: "Thiazolidinediones for the prevention of diabetes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   719 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   719 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "in the non-obese diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0241863:DIABETIC [Finding]

Phrase: "(NOD) mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mouse [Mammal]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: ":"

Phrase: "implications for human type 1 diabetes."
Processing 00000000.tx.121: Diabete Metab Res Rev18 :114 117,2002 Augstein P, Dunger A, Heinke P, Wachlin G, Berg S, Hehmke B, Salzsieder E: Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells. 

Phrase: "Diabete Metab Res Rev18"

Phrase: ":"

Phrase: "114 117,"

Phrase: "2002 Augstein P,"

Phrase: "Dunger A,"

Phrase: "Heinke P,"

Phrase: "Wachlin G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Berg S,"

Phrase: "Hehmke B,"

Phrase: "Salzsieder E"

Phrase: ":"

Phrase: "Prevention of autoimmune diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1659987:diabetes prevention [Educational Activity]
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]

Phrase: "in NOD mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "by troglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "associated with modulation of ICAM-1 expression"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0063695:ICAM-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1334074:ICAM1 [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0443264:Modulation [Spatial Concept]
   748   C0598077:I-CAM [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "on pancreatic islet cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   983   C0734999:Pancreatic islet cell [Cell]
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
           Pancreatic islet
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "IFN-gamma expression in splenic T cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.122: Biochem Biophys Res Commun304 :378 384,2003[Medline] Nezhentsev S, Guja C, McCormack R, Cooper J, Howson JMM, Nutland S, Rance H, Walker N, Undlien D, Ronningen KS, Tuomilehto-Wolf E, Tuomilehto J, Ionescu-Tirgoviste C, Gale EAM, Bingley PJ, Gillespie KM, Savage DA, Carson DJ, Patterson CC, Maxwell AP, Todd JA: The ARG241 allele of the intercellular adhesion molecule-1 is associated with a reduced risk of type 1 diabetes. 

Phrase: "Biochem Biophys Res Commun304"

Phrase: ":"

Phrase: "378 384,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nezhentsev S,"

Phrase: "Guja C,"

Phrase: "McCormack R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Cooper J,"

Phrase: "Howson JMM,"

Phrase: "Nutland S,"

Phrase: "Rance H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Walker N,"

Phrase: "Undlien D,"

Phrase: "Ronningen KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Tuomilehto-Wolf E,"

Phrase: "Tuomilehto J,"

Phrase: "Ionescu-Tirgoviste C,"

Phrase: "Gale EAM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1719788:EAM [Disease or Syndrome]

Phrase: "Bingley PJ,"

Phrase: "Gillespie KM,"

Phrase: "Savage DA,"

Phrase: "Carson DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Patterson CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538933:CC [Cell Component]

Phrase: "Maxwell AP,"

Phrase: "Todd JA"

Phrase: ":"

Phrase: "The ARG241 allele of the intercellular adhesion molecule-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "associated with a reduced risk of type 1 diabetes."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   790   C0011854:Type 1 diabetes [Disease or Syndrome]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C0441729:Type 1 [Classification]
   762   C0966318:RISK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1171304:diabetes risk [Quantitative Concept]
   762   C1320657:Diabetes type [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0035647:Risk [Qualitative Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0392756:Reduced [Qualitative Concept]
   742   C1547052:*Type [Quantitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.123: Lancet362 :1723 1724,2003[Medline] Bain SC, Todd JA, Barnett AH: The British Diabetic Association: Warren repository. 

Phrase: "Lancet362"

Phrase: ":"

Phrase: "1723 1724,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bain SC,"

Phrase: "Todd JA,"

Phrase: "Barnett AH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: ":"

Phrase: "The British Diabetic Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: ":"

Phrase: "Warren repository."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872261:Repository [Manufactured Object]
Processing 00000000.tx.124: Autoimmunity7 :83 85,1990[Medline] Lernmark A, Ducat L, Eisenbarth G, Ott J, Permutt MA, Rubenstein P, Spielman R: Family cell lines available for research. 

Phrase: "Autoimmunity7"

Phrase: ":"

Phrase: "83 85,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lernmark A,"

Phrase: "Ducat L,"

Phrase: "Eisenbarth G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ott J,"

Phrase: "Permutt MA,"

Phrase: "Rubenstein P,"

Phrase: "Spielman R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Family cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "available for research."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]
Processing 00000000.tx.125: Am J Hum Genet47 :1028 1030,1990[Medline] Patterson CC, Carson DJ, Hadden DR, the Northern Ireland Diabetes Study Group: Epidemiology of childhood IDDM in Northern Ireland 19891994: low incidence in areas with highest population density and most household crowding. 

Phrase: "Am"

Phrase: "J Hum Genet47"

Phrase: ":"

Phrase: "1028 1030,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Patterson CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538933:CC [Cell Component]

Phrase: "Carson DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Hadden DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "the Northern Ireland Diabetes Study Group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]

Phrase: ":"

Phrase: "Epidemiology of childhood IDDM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   770   C0014508:epidemiology [Functional Concept]
   770   C0699910:epidemiology [Health Care Activity]

Phrase: "in Northern Ireland 19891994"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028415:Northern Ireland [Geographic Area]
   827   C0022067:Ireland [Geographic Area]
   827   C1709269:Northern [Spatial Concept]

Phrase: ":"

Phrase: "low incidence in areas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "with highest population density"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0032665:Population Density [Quantitative Concept]
   827   C0178587:density [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "and"

Phrase: "most household crowding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010383:Crowding [Social Behavior]
   861   C0040433:Crowding [Anatomical Abnormality]
Processing 00000000.tx.126: Diabetologia39 :1063 1069,1996[Medline] Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, Reunanen A, Virtala E, Kaprio EA, Akerblom HK, the Childhood Diabetes in Finland (DiMe) Study Group: Epidemiology of childhood diabetes mellitus in Finland: background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. 

Phrase: "Diabetologia39"

Phrase: ":"

Phrase: "1063 1069,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tuomilehto J,"

Phrase: "Lounamaa R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Tuomilehto-Wolf E,"

Phrase: "Reunanen A,"

Phrase: "Virtala E,"

Phrase: "Kaprio EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Akerblom HK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "the Childhood Diabetes in Finland"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(DiMe"

Phrase: ")"

Phrase: "Study Group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0441833:Group [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "Epidemiology of childhood diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   760   C0014508:epidemiology [Functional Concept]
   760   C0699910:epidemiology [Health Care Activity]

Phrase: "in Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: ":"

Phrase: "background of a nationwide study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706907:Background [Conceptual Entity]

Phrase: "of type 1 (insulin-dependent) diabetes mellitus."
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   913   C0011854:Diabetes Mellitus, Type 1 [Disease or Syndrome]
           Diabetes Mellitus, Insulin-Dependent
           Type 1 diabetes
           Insulin Dependent Diabetes
   876   C1320657:type diabetes [Finding]
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0441729:Type 1 [Classification]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0332307:Type [Qualitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1547052:*Type [Quantitative Concept]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1701901:Dependent [Qualitative Concept]
   799   C3244310:dependent [Functional Concept]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.127: Diabetologia35 :70 76,1992[Medline] Cordell HJ, Clayton DG: A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. 

Phrase: "Diabetologia35"

Phrase: ":"

Phrase: "70 76,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cordell HJ,"

Phrase: "Clayton DG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: ":"

Phrase: "A unified stepwise regression procedure for evaluating"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   748   C1948041:Procedure [Therapeutic or Preventive Procedure]
   748   C2700391:Procedure [Activity]
   748   C3274430:PROCEDURE [Health Care Activity]
   748   C3538935:Procedure [Idea or Concept]
   748   C3539779:Procedure [Intellectual Product]

Phrase: "the relative effects of polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "within a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "case/control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0872128:case control [Health Care Activity]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "family data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ":"

Phrase: "application to HLA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0185125:Application [Health Care Activity]
   790   C1947919:Application [Intellectual Product]
   790   C2347934:Application [Intellectual Product]
   790   C3539080:APPLICATION [Quantitative Concept]

Phrase: "in type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.128: Am J Hum Genet70 :124 141,2002[Medline]

Phrase: "Am"

Phrase: "J Hum Genet70"

Phrase: ":"

Phrase: "124 141,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

